Hennrich U - Search Results

1

[⁶⁸Ga]Ga-PSMA-11: The First FDA-Approved ⁶⁸Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer.

Hennrich U, Eder M. Hennrich U, et al. Pharmaceuticals (Basel). 2021 Jul 23;14(8):713. doi: 10.3390/ph14080713. Pharmaceuticals (Basel). 2021. PMID: 34451810 Free PMC article. Review.

2

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.

Eder M, Neels O, Müller M, Bauder-Wüst U, Remde Y, Schäfer M, Hennrich U, Eisenhut M, Afshar-Oromieh A, Haberkorn U, Kopka K. Eder M, et al. Among authors: hennrich u. Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779. Pharmaceuticals (Basel). 2014. PMID: 24983957 Free PMC article.

3

Lutathera^®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy.

Hennrich U, Kopka K. Hennrich U, et al. Pharmaceuticals (Basel). 2019 Jul 29;12(3):114. doi: 10.3390/ph12030114. Pharmaceuticals (Basel). 2019. PMID: 31362406 Free PMC article. Review.

4

[⁶⁸Ga]Ga-DOTA-TOC: The First FDA-Approved ⁶⁸Ga-Radiopharmaceutical for PET Imaging.

Hennrich U, Benešová M. Hennrich U, et al. Pharmaceuticals (Basel). 2020 Mar 3;13(3):38. doi: 10.3390/ph13030038. Pharmaceuticals (Basel). 2020. PMID: 32138377 Free PMC article. Review.

5

Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [¹⁸F]PSMA-1007, a PET Tracer for the Imaging of Prostate Cancer.

Katzschmann I, Marx H, Kopka K, Hennrich U. Katzschmann I, et al. Among authors: hennrich u. Pharmaceuticals (Basel). 2021 Feb 25;14(3):188. doi: 10.3390/ph14030188. Pharmaceuticals (Basel). 2021. PMID: 33669095 Free PMC article.

6

[¹⁷⁷Lu]Lu-PSMA-617 (Pluvicto^TM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer.

Hennrich U, Eder M. Hennrich U, et al. Pharmaceuticals (Basel). 2022 Oct 20;15(10):1292. doi: 10.3390/ph15101292. Pharmaceuticals (Basel). 2022. PMID: 36297404 Free PMC article. Review.

7

Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression.

Hennrich U, Seyler L, Schäfer M, Bauder-Wüst U, Eisenhut M, Semmler W, Bäuerle T. Hennrich U, et al. Bioorg Med Chem. 2012 Feb 15;20(4):1502-10. doi: 10.1016/j.bmc.2011.12.052. Epub 2012 Jan 2. Bioorg Med Chem. 2012. PMID: 22264762

8

[Initiation of clinical multicentre studies with local radiotracer production - Regulatory environment and radiopharmaceutical-organisational aspects].

Zippel C, Neels OC, Hennrich U, Giesel FL, Kopka K. Zippel C, et al. Among authors: hennrich u. Nuklearmedizin. 2019 Mar;58(2):77-85. doi: 10.1055/a-0840-3133. Epub 2019 Mar 27. Nuklearmedizin. 2019. PMID: 30917396 German.

9

Theranostic cRGD-BioShuttle Constructs Containing Temozolomide- and Cy7 For NIR-Imaging and Therapy.

Wiessler M, Hennrich U, Pipkorn R, Waldeck W, Cao L, Peter J, Ehemann V, Semmler W, Lammers T, Braun K. Wiessler M, et al. Among authors: hennrich u. Theranostics. 2011;1:381-94. doi: 10.7150/thno/v01p0381. Epub 2011 Dec 11. Theranostics. 2011. PMID: 22211144 Free PMC article.

10

BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies.

Braun K, Beining M, Wiessler M, Lammers T, Pipkorn R, Hennrich U, Nokihara K, Semmler W, Debus J, Waldeck W. Braun K, et al. Among authors: hennrich u. Int J Med Sci. 2012;9(5):339-52. doi: 10.7150/ijms.4414. Epub 2012 Jul 1. Int J Med Sci. 2012. PMID: 22811608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters